An intervention study of Xuebijing injection(血必净注射液) on peripheral T-lymphocyte subpopulations in patients with severe trauma
Weidong Huang, Shao Yi-fu
Abstract
Weidong Huang, Shao Yi-fu
Abstract
Objective To investigate the effect and clinical significance of Xuebijing injection(血必净注射液)on peripheral T-lymphocyte subpopulations in patients with severe trauma.Methods Thirty-three patients with severe trauma were divided into a control group (n=16) and a treatment group(n=17).The patients of two groups were all treated conventionally,and the only difference was that Xuebijing injection was given to the treatment group at the early stage.The CD4+ and CD8+ subpopulations of T-lymphocyte in the peripheral blood were detected respectively at admission of hospitalization,and the 3rd and 5th day after trauma by double antibody labeling and flow cytometry.Results The CD4+ T-lymphocytes and CD4+/CD8+ ratio of peripheral blood in patients with severe trauma all decreased markedly at the 3rd and 5th day after trauma(CD4+:(32.40±6.02)% and(34.19±5.63)%,respectively vs.(45.09±6.57)% in control group,(34.30±5.46)% and(38.55±6.47)%,respectively vs.(46.10±6.02)% in treatment group;CD4+/CD8+ ratio: 1.11±0.20 and 1.15±0.20,respectively vs.1.60±0.20 in control group,1.20±0.22 and 1.32±0.24,respectively vs.1.66±0.24 in treatment group,all P0.01).Furthermore,compared with the control group, the peripheral CD4+ T-lymphocytes and CD4+/CD8+ ratio of treatment group elevated obviously at the 5th day after trauma,the differences being statistically significant((38.55±6.47)% and 1.32±0.24 vs.(34.19±5.63)% and 1.15±0.20 both P0.05).Conclusion In the treatment of patients with severe trauma,on the basis of conventional therapy,the early use of Xuebijing injection can quickly correct the disorder or inhibition of helper/suppressor T-lymphocytes immuno-inflammatory regulating network,and help to maintain a more balanced profile of immunologic function.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effect and clinical significance of Xuebijing injection(血必净注射液)on peripheral T-lymphocyte subpopulations in patients with severe trauma.Methods Thirty-three patients with severe trauma were divided into a control group (n=16) and a treatment group(n=17).The patients of two groups were all treated conventionally,and the only difference was that Xuebijing injection was given to the treatment group at the early stage.The CD4+ and CD8+ subpopulations of T-lymphocyte in the peripheral blood were detected respectively at admission of hospitalization,and the 3rd and 5th day after trauma by double antibody labeling and flow cytometry.Results The CD4+ T-lymphocytes and CD4+/CD8+ ratio of peripheral blood in patients with severe trauma all decreased markedly at the 3rd and 5th day after trauma(CD4+:(32.40±6.02)% and(34.19±5.63)%,respectively vs.(45.09±6.57)% in control group,(34.30±5.46)% and(38.55±6.47)%,respectively vs.(46.10±6.02)% in treatment group;CD4+/CD8+ ratio: 1.11±0.20 and 1.15±0.20,respectively vs.1.60±0.20 in control group,1.20±0.22 and 1.32±0.24,respectively vs.1.66±0.24 in treatment group,all P0.01).Furthermore,compared with the control group, the peripheral CD4+ T-lymphocytes and CD4+/CD8+ ratio of treatment group elevated obviously at the 5th day after trauma,the differences being statistically significant((38.55±6.47)% and 1.32±0.24 vs.(34.19±5.63)% and 1.15±0.20 both P0.05).Conclusion In the treatment of patients with severe trauma,on the basis of conventional therapy,the early use of Xuebijing injection can quickly correct the disorder or inhibition of helper/suppressor T-lymphocytes immuno-inflammatory regulating network,and help to maintain a more balanced profile of immunologic function.
Key concepts: CD8, Medicine, Peripheral, Internal medicine, Gastroenterology, Peripheral blood, Lymphocyte subsets, T lymphocyte